Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
25,088,227
-
Share change
-
-12,041,593
-
Total reported value
-
$361,328,950
-
Price per share
-
$14.40
-
Number of holders
-
42
-
Value change
-
-$247,337,592
-
Number of buys
-
20
-
Number of sells
-
19
Institutional Holders of EXSCIENTIA PLC - ADS (EXAI) as of Q1 2022
As of 31 Mar 2022,
EXSCIENTIA PLC - ADS (EXAI) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,088,227 shares.
The largest 10 holders included
SB Global Advisers Ltd, BAILLIE GIFFORD & CO, Laurion Capital Management LP, PLATINUM INVESTMENT MANAGEMENT LTD, Bill & Melinda Gates Foundation, MIC Capital Management UK LLP, PICTET ASSET MANAGEMENT SA, PRICE T ROWE ASSOCIATES INC /MD/, MARSHALL WACE, LLP, and Pivotal bioVenture Partners Investment Advisor LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.